Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.58.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.58.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.8.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.8.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.8.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.8.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.1.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.1.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
JN.1.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDD.1.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDD.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDD.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDD.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDNORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDNENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
XDNENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDNNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LT.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LT.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LT.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.8.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
JN.1.8.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.8.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.8.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LV.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LV.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LV.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LV.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.54.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.54.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.54.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.54.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.30.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.30.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.30.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.30.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.1.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.1.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.1.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used